Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Zoledronic Acid in the Prevention of Bone Loss in Acute Spinal Cord Injury

NCT02042872 is registered in ClinicalTrials.gov with James J. Peters Veterans Affairs Medical Center as lead sponsor.

NCT NCT02042872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Zoledronic Acid in the Prevention of Bone Loss in Acute Spinal Cord Injury
Lead sponsor
James J. Peters Veterans Affairs Medical Center
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
July 31, 2012
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disuse osteoporosis